Ligand profile
ZINC120410797
Virtual-screening candidate from ZINC.
Bound to: KP13_03933 — Pirin-like protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC120410797- UniProt (similar protein)
O00625- Tanimoto
- 0.618
- Target protein
- KP13_03933
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 42.0
- −1 ≤ LogP ≤ 5 4.24
- MW ≤ 500 Da 294.3
- LogP ≤ 5 4.24
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 42.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ccc2cc(C(=O)Nc3cc(F)ccc3C)ccc2n1Cc1ccc2cc(C(=O)Nc3cc(F)ccc3C)ccc2n1
InChI=1S/C18H15FN2O/c1-11-3-7-15(19)10-17(11)21-18(22)14-6-8-16-13(9-14)5-4-12(2)20-16/h3-10H,1-2H3,(H,21,22)InChI=1S/C18H15FN2O/c1-11-3-7-15(19)10-17(11)21-18(22)14-6-8-16-13(9-14)5-4-12(2)20-16/h3-10H,1-2H3,(H,21,22)
LYVQYNHBSMLDOV-UHFFFAOYSA-NLYVQYNHBSMLDOV-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- FJH
- Homolog
- O00625
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC120410797 →
- ZINC ZINC20 ZINC120410797 →
- UniProt UniProt O00625 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC120410797”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03933.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 10
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).